These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 2372858)

  • 41. Comparison of North American and European malignant hyperthermia group halothane contracture testing protocols in swine.
    Fletcher JE; Conti PA; Rosenberg H
    Acta Anaesthesiol Scand; 1991 Aug; 35(6):483-7. PubMed ID: 1897341
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A blinded comparison of noninvasive, in vivo phosphorus nuclear magnetic resonance spectroscopy and the in vitro halothane/caffeine contracture test in the evaluation of malignant hyperthermia susceptibility.
    Olgin J; Rosenberg H; Allen G; Seestedt R; Chance B
    Anesth Analg; 1991 Jan; 72(1):36-47. PubMed ID: 1984374
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Propofol is a 'safe' anaesthetic agent in malignant hyperthermia susceptible patients.
    McKenzie AJ; Couchman KG; Pollock N
    Anaesth Intensive Care; 1992 May; 20(2):165-8. PubMed ID: 1595850
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro contracture tests in patients with various neuromuscular diseases.
    Heytens L; Martin JJ; Van de Kelft E; Bossaert LL
    Br J Anaesth; 1992 Jan; 68(1):72-5. PubMed ID: 1739572
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Diagnosis of susceptibility to malignant hyperthermia using the in vitro contracture test].
    Klein W; Spiess-Kiefer C; Küther G; Pongratz D; Lehmann-Horn F
    Anaesthesist; 1987 Dec; 36(12):685-91. PubMed ID: 2830805
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sevoflurane is less sensitive than halothane for in vitro detection of malignant hyperthermia susceptibility.
    Johannsen S; Klingler W; Schneiderbanger D; Heiderich S; Roewer N; Schuster F
    Acta Anaesthesiol Scand; 2013 Oct; 57(9):1161-6. PubMed ID: 23957432
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [In-vitro-effects of cocaine in skeletal muscle specimens of patients susceptible to malignant hyperthermia].
    Weisshorn R; Wappler F; Fiege M; Gerbershagen M; Schulte Am Esch J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 Mar; 37(3):138-43. PubMed ID: 11889614
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of in vitro contracture testing with ryanodine, halothane and caffeine in malignant hyperthermia and other neuromuscular disorders.
    Hopkins PM; Ellis FR; Halsall PJ
    Br J Anaesth; 1993 Apr; 70(4):397-401. PubMed ID: 8499197
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Static v. dynamic tests in the in vitro diagnosis of malignant hyperthermia susceptibility.
    Ranklev E; Fletcher R; Blomquist S
    Br J Anaesth; 1986 Jun; 58(6):646-8. PubMed ID: 3707802
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 3,5-Di-t-butyl catechol is a potent human ryanodine receptor 1 activator, not suitable for the diagnosis of malignant hyperthermia susceptibility.
    Lacava C; Michalek-Sauberer A; Kraft B; Sgaragli G; Sipos E; Höller C; Kress HG; Fusi F; Weigl LG
    Pharmacol Res; 2012 Jul; 66(1):80-7. PubMed ID: 22480578
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 4-Chloro-m-cresol test--a possible supplementary test for diagnosis of malignant hyperthermia susceptibility.
    Ording H; Glahn K; Gardi T; Fagerlund T; Bendixen D
    Acta Anaesthesiol Scand; 1997 Sep; 41(8):967-72. PubMed ID: 9311392
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic effects on the variability of the halothane and caffeine muscle contracture tests.
    Urwyler A; Censier K; Kaufmann MA; Drewe J
    Anesthesiology; 1994 Jun; 80(6):1287-95. PubMed ID: 8010475
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In-vitro contracture testing for susceptibility to malignant hyperthermia: can halothane be replaced?
    Metterlein T; Schuster F; Kranke P; Roewer N; Anetseder M
    Eur J Anaesthesiol; 2011 Apr; 28(4):251-5. PubMed ID: 20827211
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of veratridine on mechanical responses of human malignant hyperthermic muscle fibers.
    Adnet PJ; Etchrivi TS; Halle I; Haudecoeur G; Reyford HG; Krivosic-Horber RM
    Acta Anaesthesiol Scand; 1998 Feb; 42(2):246-53. PubMed ID: 9509211
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Contracture responses of the muscle from a patient with malignant hyperthermia to drugs].
    Iwatsuki N; Koga Y; Amaha K
    Masui; 1984 Jul; 33(7):731-6. PubMed ID: 6502923
    [No Abstract]   [Full Text] [Related]  

  • 56. Histological support for the difference between malignant hyperthermia susceptible (MHS), equivocal (MHE) and negative (MHN) muscle biopsies.
    Mezin P; Payen JF; Bosson JL; Brambilla E; Stieglitz P
    Br J Anaesth; 1997 Sep; 79(3):327-31. PubMed ID: 9389850
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Contraction-relaxation coupling of skeletal muscle in patients susceptible to malignant hyperthermia].
    Etchrivi TS; Adnet P; Haudecoeur G; Teneur F; Stix I; Krivosic-Horber RM
    Ann Fr Anesth Reanim; 2002 Jun; 21(6):471-7. PubMed ID: 12134592
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of the phosphodiesterase-III inhibitor enoximone on skeletal muscle specimens from malignant hyperthermia susceptible patients.
    Fiege M; Wappler F; Scholz J; Weisshorn R; von Richthofen V; Schulte am Esch J
    J Clin Anesth; 2000 Mar; 12(2):123-8. PubMed ID: 10818326
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative analysis of in vitro contracture tests with ryanodine and a combination of ryanodine with either halothane or caffeine: a comparative investigation in malignant hyperthermia.
    Bendahan D; Guis S; Monnier N; Kozak-Ribbens G; Lunardi J; Ghattas B; Mattei JP; Cozzone PJ
    Acta Anaesthesiol Scand; 2004 Sep; 48(8):1019-27. PubMed ID: 15315621
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changes in ryanodine-induced contractures by stimulus frequency in malignant hyperthermia susceptible and malignant hyperthermia nonsusceptible dog skeletal muscle.
    Sudo RT; Nelson TE
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1331-6. PubMed ID: 9316843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.